BioSpace News Archive

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has commenced a proposed underwritten public offering of shares of common stock.

New Jersey hospitals have partnered with the New Jersey Hospital Association to develop heightened visitor restrictions to protect patients statewide amid the coronavirus outbreak.

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report its fourth quarter and full year 2019 financial results on March 16, 2020.

Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders will release its financial results for the fourth quarter and full year ended December 31, 2019,

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Melissa Layman has been named Chief Commercial Officer (CCO).

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today reported audited financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on recent developments in its business.

As bottles of soap are flying off the shelves and hand sanitizer is in short supply since the global spread of Novel Coronavirus COVID-19, people are paying more attention to hand washing practices.

Conatus Pharmaceuticals Inc. announced financial results for the fourth quarter and full year ended December 31, 2019, and provided an update on its strategic process.

MedChi CTO Partners with DrFirst to Provide Backline with Telehealth for its Physician Practices

ADVANZ PHARMA Corp. Limited announced it intends to release its fourth quarter and 2019 financial results before market open on Wednesday, March 25, 2020.